The biotechnology company BeiGene, founded in China, is moving its legal headquarters from the Cayman Islands to Basel.

Fintel reports that on May 27, 2025, Canaccord Genuity initiated coverage of Niagen Bioscience (NasdaqCM:NAGE) with a Buy ...

Biotechnology company Regeneron will acquire 23andMe out of bankruptcy for $256 million, with a plan to keep the DNA-testing ...

Big Biotech Biogen is venturing into the city, paying $16 million in cash to partner up with an RNAi company to build ...

Eikon Therapeutics, a Bay Area biotech startup with $1.1 billion in funding, is laying off dozens of employees and pointing ...

Niagen Bioscience, Inc. is headquartered in Los Angeles, CA. The company operates out of three main business segments: ...

Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer ...

The proposed transaction with Regeneron includes 23andMe’s personal genome service and total health and research services.

Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease is proud to announce a strategic collaboration ...

Job cuts at home-grown pharma companies like Arvinas and RallyBio and federal policies challenge CT biotech 'ecosystem' that ...

The Holliston, Massachusetts-based company said it had a loss of $1.14 per share. Losses, adjusted for one-time gains and costs, were 1 cent per share. While Harvard Bioscience, Inc. ( NASDAQ ...